|1.||Aneja, Ritu: 3 articles (08/2015 - 06/2010)|
|2.||Madan, Jitender: 2 articles (08/2015 - 12/2014)|
|3.||Katyal, Anju: 1 article (08/2015)|
|4.||Katare, Om Prakash: 1 article (08/2015)|
|5.||Jain, Upendra Kumar: 1 article (08/2015)|
|6.||Kaur, Kamalpreet: 1 article (08/2015)|
|7.||Sodhi, Rupinder Kaur: 1 article (08/2015)|
|8.||Baruah, Bharat: 1 article (12/2014)|
|9.||Gundala, Sushma R: 1 article (12/2014)|
|10.||Hamelberg, Donald: 1 article (12/2014)|
|1.||Colonic Neoplasms (Colon Cancer)
08/01/2015 - "The noteworthy anti-inflammatory activity of WGA-CTS-MS-Red-Br-Nos against acute colitis may be attributed to enhanced drug delivery, affinity and utmost drug exposure at inflamed mucosal layers of colon. "
08/01/2015 - "However, physicochemical limitations of Red-Br-Nos like low aqueous solubility (0.43×10(-3) g/mL), high lipophilicity (logP∼2.94) and ionization at acidic pH greatly encumber the scale-up of oral drug delivery systems for the management of colitis. "
08/01/2015 - "In vitro release studies carried out on WGA-CTS-MS-Red-Br-Nos and CTS-MS-Red-Br-Nos indicated that SCF with colitis milieu (pH∼4.7) favored the controlled release of Red-Br-Nos, owing to solubilization at acidic pH. Consistently, in vivo investigation also demonstrated the utility of WGA-CTS-MS-Red-Br-Nos, which remarkably attenuated the DSS encouraged neutrophil infiltration, myeloperoxidase activity, and pro-inflammatory cytokine production in C57BL6J mice, as compared to CTS-MS-Red-Br-Nos and Red-Br-Nos suspension. "
|3.||Prostatic Neoplasms (Prostate Cancer)
01/01/2012 - "Recently, we demonstrated that a noscapinoid member, reduced bromonoscapine, (S)-3-(R)-9-bromo-5-(4,5-dimethoxy-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo-[4,5-g]isoquinoline (Red-Br-nos), induces reactive oxygen species (ROS)-mediated autophagy and caspase-independent death in prostate cancer PC-3 cells. "
06/11/2010 - "Here we demonstrate that a tubulin-binding noscapine analog, (R)-9-bromo-5-((S)-4,5-dimethoxy-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]-di-oxolo[4,5-g]isoquinoline (Red-Br-nos), exerts a novel autophagic response followed by apoptotic cell death in human prostate cancer PC-3 cells. "
|3.||Reactive Oxygen Species (Oxygen Radicals)